Inactive Instrument

Other languages Flexion Therapeutics, Inc.

Equities

FLXN

US33938J1060

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Flexion Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-12
Flexion Therapeutics : Health Care Stocks Sliding in Late Monday Trading	21-10-11
Flexion Therapeutics : Agrees to Be Acquired by Pacira BioSciences; Shares Soar Pre-Bell	21-10-11
Pacira BioSciences : adds non-opioid pain drugs with $427.5 million Flexion buy	21-10-11
Pacira BioSciences : to buy Flexion for $427.5 million	21-10-11
Flexion Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-04
Flexion Therapeutics : Earnings Flash (FLXN) FLEXION THERAPEUTICS Reports Q2 Revenue $28.2M, vs. Street Est of $28.9M	21-08-04
Flexion Therapeutics, Inc. Reiterates Net Sales Guidance for the Full Year 2021	21-08-04
Flexion Therapeutics : Names New Chief Medical Officer	21-06-09
Seres Therapeutics : Names David Arkowitz Chief Financial Officer	21-05-20
Flexion Therapeutics : Q1 Loss Narrows as Revenue Rises	21-05-12
Flexion Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-12
Flexion Therapeutics : Earnings Flash (FLXN) FLEXION THERAPEUTICS Posts Q1 Revenue $24.6M, vs. Street Est of $24.8M	21-05-12
Flexion Therapeutics, Inc. Provides Sales Guidance for 2021	21-05-12
Earnings Reaction History: Flexion Therapeutics Inc, 71.4% Follow-Through Indicator, 8.8% Sensitive	21-05-12
Flexion Therapeutics : Reports Preliminary Q1 Zilretta Sales, Sets Full-Year Guidance -- Stock Rises 3% After-Hours	21-04-13
Flexion Therapeutics, Inc. Provides Financial Guidance for 2021	21-04-13
Flexion Therapeutics : Commences Treatment in Phase 1B Trial of Post-Operative Pain Medication	21-03-31
Flexion Therapeutics : Posts Narrower 2020 Net Loss of $2.53 a Share on Higher Revenue	21-03-10
Flexion Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-10

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Flexion Therapeutics, Inc.

Equities

FLXN

US33938J1060

Other languages

Filters